Carpa Healthcare

What Carpa Healthcare does

Carpa Healthcare Limited is a privately held Nigerian pharmaceutical manufacturer and distributor founded in 2016 and headquartered in Uyo, Akwa Ibom State. The company produces a portfolio of branded generic medicines spanning five therapeutic categories: antimalarials (Carpatem, Carpatem Plus, Carpatem Softgel, Carpatem Plus Softgel, Arteminix injection), antibiotics (Gentyx, Ceftynet), antiretrovirals (Rilshield, Tenoveil), antidiabetics (Glucentra), and consumer sanitary products (Padluxe Lite, Midi, and Maxi). Its product line targets disease burdens prevalent in sub-Saharan Africa, including drug-resistant malaria, HIV/AIDS, bacterial infections, type 2 diabetes, and menstrual hygiene.

The company operates a proprietary technology stack consisting of an online distributor portal (app.carpahealthcare.com), online and offline payment-enabled inventory management software, and a track-and-trace system that records product lifecycle from manufacturing through to final distribution terminal to combat counterfeit and substandard medicines. Operational premises are PCN-approved following a multi-layered regulatory inspection, products are NAFDAC-registered, and the company adheres to NAFDAC's Good Pharmacovigilance Practice Guidelines. In August 2025, Carpa Healthcare became a member of the United Nations Global Compact.

The business model is B2B distributor-led: Carpa Healthcare sells to registered distributors who are onboarded through a corporate registration and pharmaceutical licensing process, with pricing undisclosed and quotes delivered via the secure portal. The company also partners with NGOs, government ministries, and development partners to distribute Padluxe sanitary products at limited margin in underserved regions. Revenue is generated through one-time sales of pharmaceutical products to distributors, pharmacies, hospitals, and healthcare providers across Nigeria, with stated intent to expand into the broader West African sub-region. The company is self-funded with no disclosed external equity investment.

Name

Carpa Healthcare

Legal name

Carpa Healthcare Limited

Website

https://carpahealthcare.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Carpa Healthcare Limited is a Nigerian pharmaceutical manufacturer founded in 2016 that produces branded generic medicines (antimalarials, antibiotics, antiretrovirals, antidiabetics) and sanitary products, distributing them through a registered B2B distributor network with proprietary online ordering and track-and-trace software across Nigeria and West Africa.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Antimalarial drugs
• Antiretroviral therapy
• Menstrual hygiene products

Headquarters

HQ city

Uyo

HQ country

Nigeria

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Carpa Healthcare generates revenue through the sale of branded generic pharmaceutical products including antimalarials, antibiotics, antiretrovirals, antidiabetics, and sanitary products to registered distributors, pharmacies, hospitals, and healthcare providers across Nigeria and West Africa.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Carpa Healthcare manufactures and distributes branded generic pharmaceutical products including antimalarials, antibiotics, antiretrovirals, antidiabetics, and sanitary products to registered distributors, pharmacies, hospitals, and healthcare providers across Nigeria and West Africa. The company operates a proprietary distributor portal with online inventory management and track and trace capabilities for product authenticity verification.

Product overview

Carpa Healthcare is a Nigerian pharmaceutical company offering a diversified portfolio of branded generic medicines and consumer health products. The product portfolio spans five therapeutic categories: (1) Antimalarials including Carpatem, Carpatem Plus, Carpatem Softgel, Carpatem Plus Softgel, and Arteminix injection - all containing Artemether/Lumefantrine formulations for uncomplicated malaria treatment; (2) Antibiotics including Gentyx (Gentamicin injection) and Ceftynet (Cefixime tablets); (3) Antiretrovirals including Rilshield (Rilpivirine) and Tenoveil (Tenofovir alafenamide) for HIV/AIDS and HBV treatment; (4) Antidiabetics including Glucentra (Metformin/Glibenclamide combination); and (5) Consumer sanitary products including Padluxe Lite, Midi, and Maxi sanitary pads. The company operates through a distributor network with an online inventory management portal and maintains regulatory compliance with NAFDAC and Pharmacy Council of Nigeria standards.

Differentiator

Problem solved

Functional benefit

Brands

• Padluxe: Sanitary pad brand for menstrual hygiene management, manufactured to UNICEF specifications
• Rilshield
• Tenoveil
• Carpatem
• Carpatem Plus
• Carpatem Softgel
• Carpatem Plus Softgel
• Arteminix
• Gentyx
• Ceftynet
• Glucentra

Products and services

• Padluxe Lite High-quality, highly absorbent sanitary pad for menstruation management. Length 280mm, absorbable volume 100ml. UNICEF specification compliant, fragrance-free, winged design for medium flow.
• Padluxe Midi High-quality, highly absorbent sanitary pad for menstruation management. Length 320mm, absorbable volume 153ml. Designed to remain dry, prevent leakage, and be safe for prolonged skin contact.
• Padluxe Maxi High-quality, highly absorbent sanitary pad with 7-layer construction for menstruation management. Length 400mm, width 155mm, absorbable volume 300ml. Features perforated polypropylene top layer, cellulose-based pulp core, and polyethylene bottom layer for leak-proof protection.
• Carpatem Softgel Artemether/Lumefantrine softgel capsule formulation containing 20mg Artemether and 120mg Lumefantrine. Prescription medication for treatment of uncomplicated drug-resistant malaria caused by P. falciparum and P. malariae.
• Carpatem Plus Softgel Artemether/Lumefantrine softgel capsule formulation containing 80mg Artemether and 480mg Lumefantrine. Higher-dose formulation for treatment of uncomplicated drug-resistant malaria.
• Carpatem Artemether/Lumefantrine tablet containing 20mg Artemether and 120mg Lumefantrine. Prescription medication for treatment of uncomplicated drug-resistant malaria caused by P. falciparum and P. malariae.
• Carpatem Plus Artemether/Lumefantrine tablet containing 80mg Artemether and 480mg Lumefantrine. Higher-dose formulation for treatment of uncomplicated drug-resistant malaria in adults and children.
• Arteminix Artemether injection 80mg/ml in 1ml ampoule. Antimalarial agent for treatment of uncomplicated malaria caused by chloroquine-resistant P. falciparum and P. malariae. Also used for treating schistosomiasis when combined with anthelmintic. Administered intramuscularly.
• Gentyx Gentamicin Sulfate Injection 80mg/2ml. Aminoglycoside antibiotic for treatment of bacterial infections including bone infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, and sepsis. Administered IV/IM.
• Ceftynet Cefixime 400mg tablet. Third-generation cephalosporin antibiotic for treatment of bacterial infections including ear infections, bronchitis, pneumonia, urinary tract infections, and gonorrhea. Orally administered.
• Rilshield Rilpivirine 25mg film-coated tablet. Second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV/AIDS treatment. Recommended for patients with viral load of 100,000 copies/mL or less at therapy initiation.
• Tenoveil Tenofovir alafenamide fumarate (TAF) 25mg tablet. Antiviral medication for treatment of HIV/AIDS and Hepatitis B virus (HBV) infections. Known for greater antiviral activity and distribution into lymphoid tissues.
• Glucentra Metformin Hydrochloride 250mg and Glibenclamide 1.25mg combination capsule. Hypoglycemic agent for treatment of type 2 diabetes mellitus in adults, replacing previous combination therapy in patients with stable glycaemia.

Quantifiable outcome

• Member of United Nations Global Compact, joining over 20,000 companies worldwide committed to sustainability principles
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• United Nations Global CompactcoreStrategic or Co-development Partner · 8 August 2025Carpa Healthcare became a member of the UN Global Compact, the world's largest sustainability initiative. The company commits to aligning its operations with Ten UN Global Compact Principles covering human rights, labor, environment, and anti-corruption, contributing to the Sustainable Development Goals.
• Pharmacy Council of Nigeria (PCN)coreStrategic or Co-development PartnerOperational premises in Uyo, Akwa Ibom State received formal approval from PCN following rigorous multi-layered inspection of infrastructure, storage conditions, staff qualifications, SOPs, and quality assurance systems.
• National Agency for Food and Drug Administration and Control (NAFDAC)coreStrategic or Co-development PartnerProducts regulated by NAFDAC. The company maintains pharmacovigilance commitments aligned with NAFDAC's Good Pharmacovigilance Practice (GVP) Guidelines for drug safety monitoring and reporting.
• Association of Community Pharmacists of Nigeria (ACPN)minorStrategic or Co-development PartnerListed as a regulatory partner in the healthcare ecosystem, representing community pharmacists across Nigeria.
• Pharmaceutical Society of Nigeria (PSN)minorStrategic or Co-development PartnerListed as a regulatory partner representing pharmacists in Nigeria's pharmaceutical sector.
• Nigerian Medical Association (NMA)minorStrategic or Co-development PartnerListed as a regulatory partner representing medical doctors in Nigeria.
• UNICEFminorStrategic or Co-development PartnerPadluxe sanitary products are manufactured to meet up-to-date technical specifications for disposable sanitary pads by UNICEF, ensuring quality-assured, fragrance-free, winged designs suitable for medium-to-high flow.
• Government Ministries, NGOs, and Development PartnersminorChannel Partner/ Reseller/ DistributorPadluxe partners with global partners, government ministries, non-governmental organizations, and development partners for product distribution at little to no profit.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Evans Medical (Evans Therapeutics): Long-standing Nigerian pharmaceutical manufacturer with branded generics across multiple therapeutic areas. Comparable in product breadth and distribution approach within Nigeria.
• Fidson Healthcare: Largest Nigerian pharmaceutical manufacturer by local capacity, producing branded generics across multiple therapeutic areas including antimalarials and antibiotics. Comparable product portfolio, NAFDAC-regulated, and serves the same pharmacy and hospital channels.
• Emzor Pharmaceutical Industries: Nigerian branded generics manufacturer with a broad portfolio across antimalarials, antibiotics, and analgesics. Most direct local competitor to Carpa in Nigerian generics manufacturing and distributor-led distribution.
• May & Baker Nigeria: Listed Nigerian pharmaceutical manufacturer with a long-standing branded generics portfolio. Operates in similar therapeutic categories (antimalarials, antibiotics) and uses Nigeria-wide distributor and pharmacy channels.
• Neimeth International Pharmaceuticals: Nigerian pharmaceutical company producing branded generics across antibiotics, antimalarials, and nutrition. Comparable in scale, regulatory profile, and distribution model to Carpa Healthcare.
• Swiss Pharma Nigeria (Swipha): Nigerian generics manufacturer with a portfolio spanning antibiotics, antimalarials, and consumer health. Direct competitor in the same pharmacy and hospital distribution channels.

Broad incumbents

• GSK Consumer / GSK Nigeria: Global pharma major with Nigeria operations spanning antibiotics, antimalarials, and consumer health. Competes with Carpa in selected therapeutic categories but offers a much wider portfolio.
• Cipla (Africa operations): Global generics manufacturer with material presence across Africa, particularly in antiretrovirals, antimalarials, and respiratory medicines. Overlaps with Carpa's ARV and antimalarial franchises through regional procurement channels.
• Sanofi Nigeria: Subsidiary of global pharma major selling branded and generic medicines in Nigeria across multiple therapeutic areas. Larger scale and broader portfolio, but competes directly in the same distributor-and-pharmacy channels.

Regional players

• Aspen Pharmacare: Sub-Saharan Africa's largest pharmaceutical manufacturer, headquartered in South Africa and supplying generics across the region. Comparable in therapeutic categories (ARVs, antimalarials, antibiotics) but operates primarily in Southern Africa rather than West Africa.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carpa Healthcare